Integrative colloidal gels for cranial defect repair

用于颅骨缺损修复的一体化胶体凝胶

• 批准号: 8607930
• 负责人: Cory Berkland
• 金额: $ 35.96万
• 依托单位: UNIVERSITY OF KANSAS LAWRENCE
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-03-01 至 2016-02-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8607930
• 关键词: Anabolism; Animals; Artificial nanoparticles; Biochemistry; Biocompatible Materials; Bone Cements; Bone Marrow; Bone Regeneration; Bone Tissue; Calvaria; Categories; Cephalic; Ceramics; Charge; Chemistry; Chondroitin Sulfates; Clinic; Clinical; Clinical Research; Colloids; Data; Defect; Electrostatics; Engineering; Environment; Filler; Foundations; Future; Gel; Glycosaminoglycans; Goals; Growth Factor; Hydrogels; Hydroxyapatites; In Vitro; Institutes; Lead; Liquid substance; Liver Regeneration; Medical; Mesenchymal Stem Cells; Metals; Mission; Modeling; Molds; Musculoskeletal; Natural regeneration; Necrosis; Operative Surgical Procedures; Osteogenesis; Paste substance; Pharmaceutical Preparations; Polymers; Polymethyl Methacrylate; Property; Publishing; Qualifying; Rattus; Relative (related person); Research; Research Personnel; Rheology; Signal Transduction; Site; Solid; Stress; Surface; Surgeon; Technology; Testing; Tissue Engineering; Tissues; Vascular Endothelial Growth Factors; Weight-Bearing state; base; bone; bone morphogenetic protein 2; cohesion; commercialization; controlled release; craniofacial; design; in vivo; innovation; nanoparticle; novel; osteochondral tissue; osteogenic; polysulfated glycosaminoglycan; prototype; reconstruction; repaired; scaffold; stem cell differentiation; three dimensional structure; tissue regeneration

DESCRIPTION (provided by applicant): The long-term objective of this application is to deliver a unique biomaterial that can easily be molded into place by a surgeon, and will resorb as it induces rapid tissue regeneration. Toward this objective, we invented a biomaterial based on colloidal gel technology, which we have demonstrated to be effective in calvarial defect regeneration. The key feature that distinguishes colloidal gels from the two major classes of scaffolding biomaterials (hydrogels and solid scaffolds) is their paste-like rheology, which in turn is attributed to electrostatic interaction of the nanoparticle constituents. Although this new class of scaffolds is highly versatile in its unbounded combination of possible synthetic and natural nanoparticles, we have elected to focus on a combination of naturally occurring materials with controlled release of bioactive signals. Therefore, the objective of this project is to develop a malleable material that can be spread into place in a cranial defect, while releasing bioactive factors and allowing native bone to penetrate and resorb the material. The corresponding central hypothesis is that the growth factor-loaded colloidal gels will regenerate bone in cranial defects significantly faster and more completely than unloaded colloidal gels or commercial hydroxyapatite bone fillers. To test this hypothesis, we propose three specific aims: 1) to synthesize and characterize novel colloidal gels with modulated rheological properties, 2) to engineer and refine colloidal gels in vitro, and 3) to determine the efficacy of colloidal gels in a rat cranial defect model. Building on our published characterization of prototype colloidal gels, our overall strategy will be to significantly expand our repertoire first by evaluating the rheological and release properties of a variety of combinations of specific sulfated glycosaminoglycans (GAGs, negatively charged) and hydroxyapatite nanoparticles (positively charged), which have been identified as an internally cohesive colloidal gel network. A specific subset of these combinations will then be thoroughly evaluated in vitro for their efficacy in promoting osteogenesis with rat bone marrow-derived mesenchymal stem cells (BMSCs). The most promising groups from these in vitro studies will be evaluated in critical-sized rat calvarial defects, with the project thereby culminating in the identification of the leading combination of GAGs, hydroxyapatite, and osteogenic and angiogenic signals for calvarial defect regeneration. Successful completion of this project will lay the foundation for an entirely new sub-field for tissue engineering scaffolding biomaterials. The true impact of this line of research is its extraordinary versatility and relatively straightforward set of design principles as a means to create bioresorbable, pastes of tunable consistency, with the capability for controlled release of bioactive signals. We and other investigators world- wide will be able to explore a seemingly infinite number of innovative combinations of interactive nanoparticles for applications beyond calvarial defect regeneration, from osteochondral regeneration to liver regeneration to any other conceivable application where such a material is desired.

描述（由申请人提供）：本申请的长期目标是提供一种独特的生物材料，该生物材料可以很容易地由外科医生模制到位，并且在诱导快速组织再生时会被吸收。为了实现这一目标，我们发明了一种基于胶体凝胶技术的生物材料，并已证明该材料可有效再生颅骨缺损。胶体凝胶与两大类支架生物材料（水凝胶和固体支架）的关键特征是它们的糊状流变性，这又归因于纳米颗粒成分的静电相互作用。尽管这种新型支架在可能的合成和天然纳米颗粒的无限组合方面具有高度通用性，但我们选择将重点放在天然存在的材料与生物活性信号的受控释放的组合上。因此，该项目的目标是开发一种可延展的材料，该材料可以扩散到颅骨缺损中，同时释放生物活性因子并允许天然骨渗透和再吸收该材料。相应的中心假设是，负载生长因子的胶体凝胶将比未负载的胶体凝胶或商业羟基磷灰石骨填充剂更快、更完全地使颅骨缺损中的骨再生。为了检验这一假设，我们提出了三个具体目标：1）合成和表征具有调节流变特性的新型胶体凝胶，2）在体外设计和精制胶体凝胶，3）确定胶体凝胶在大鼠颅骨中的功效缺陷模型。基于我们已发表的原型胶体凝胶的表征，我们的总体策略将是首先通过评估特定硫酸化糖胺聚糖（GAG，带负电）和羟基磷灰石纳米颗粒（带正电）的各种组合的流变学和释放特性来显着扩展我们的产品库。 ，已被确定为内部内聚的胶体凝胶网络。然后，将在体外彻底评估这些组合的特定子集在利用大鼠骨髓间充质干细胞（BMSC）促进成骨方面的功效。这些体外研究中最有前途的群体将在临界尺寸的大鼠颅骨缺损中进行评估，该项目最终将鉴定出用于颅骨缺损再生的 GAG、羟基磷灰石以及成骨和血管生成信号的主要组合。 该项目的成功完成将为组织工程支架生物材料的全新子领域奠定基础。这一系列研究的真正影响在于其非凡的多功能性和相对简单的一套设计原理，作为创建生物可吸收、稠度可调的糊剂的一种手段，并具有控制释放生物活性信号的能力。我们和世界各地的其他研究人员将能够探索看似无数的交互式纳米粒子的创新组合，用于颅骨缺损再生之外的应用，从骨软骨再生到肝脏再生，再到任何其他需要这种材料的可能应用。